BankPlus Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.17M Buy
2,762
+124
+5% +$49.4K 0.51% 32
2026
Q2
$956K Buy
2,638
+314
+14% +$107K 0.43% 38
2026
Q1
$819K Sell
2,324
-53
-2% -$18.9K 0.42% 40
2025
Q4
$778K Sell
2,377
-11
-0.5% -$3.49K 0.43% 39
2025
Q3
$674K Buy
2,388
+141
+6% +$40.9K 0.4% 43
2025
Q2
$627K Buy
2,247
+362
+19% +$103K 0.42% 45
2025
Q1
$587K Buy
1,885
+61
+3% +$18K 0.43% 45
2024
Q4
$475K Buy
+1,824
New +$541K 0.35% 57

Other funds holding AMGN

BankPlus Wealth Management's AMGN Position: Q3 2026 in Review

BankPlus Wealth Management increased its Amgen (AMGN) stake by 4.7% in Q3 2026, buying an estimated $49.4K and bringing the position to 2,762 shares worth $1.17M. The position accounts for 0.51% of the portfolio, ranked #32.

BankPlus Wealth Management first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • BankPlus Wealth Management held 2,762 shares of Amgen worth $1.17M as of Q3 2026.
  • BankPlus Wealth Management bought 124 Amgen shares in Q3 2026, an estimated $49.4K.
  • Amgen made up 0.51% of BankPlus Wealth Management's portfolio in Q3 2026, its #32 holding.
  • BankPlus Wealth Management first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on BankPlus Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.